https://scholars.lib.ntu.edu.tw/handle/123456789/567535
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Chen W.-C. | en_US |
dc.contributor.author | Lee C.-C. | en_US |
dc.contributor.author | Chien M.-N. | en_US |
dc.contributor.author | Liu S.-C. | en_US |
dc.contributor.author | Wang C.-H. | en_US |
dc.contributor.author | WEI-SHIUNG YANG | en_US |
dc.date.accessioned | 2021-07-02T02:35:16Z | - |
dc.date.available | 2021-07-02T02:35:16Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1873-9598 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048874210&doi=10.1016%2fj.ijge.2018.05.008&partnerID=40&md5=feee24afda74156adf074e11c437a34f | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/567535 | - |
dc.description.abstract | With the increasing number of aged individuals in the population and the elevated prevalence of diabetes worldwide, there are more and older people with type 2 diabetes. Unfortunately, the management of diabetes in the elderly is not easy. Older people are heterogeneous. Hypoglycemia and hyperglycemia crises are more frequent and dangerous to older patients. Comorbidities, functional impairment and the available support system may influence the management of the disease. The target of glycemic control in the elderly should be based on individual conditions. Although the number of clinical trials relating to the management of type 2 diabetes in the elderly is limited, organizations have provided guidelines or statements about type 2 diabetes in the elderly. There are approved therapies or medicines for type 2 diabetes controls, but we should have more considerations for aged patients with type 2 diabetes. ? 2018 | - |
dc.publisher | Elsevier (Singapore) Pte Ltd | - |
dc.relation.ispartof | International Journal of Gerontology | - |
dc.subject | aged; type 2 diabetes | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | 2,4 thiazolidinedione derivative; alpha glucosidase inhibitor; dipeptidyl peptidase IV inhibitor; glucagon like peptide 1 receptor agonist; glucose; insulin; meglitinide; metformin; sodium glucose cotransporter 2 inhibitor; sulfonylurea; aged; blood glucose monitoring; comorbidity; evidence based practice; functional disease; geriatric disorder; glucose blood level; glycemic control; human; hyperglycemia; hypoglycemia; multicenter study (topic); non insulin dependent diabetes mellitus; polypharmacy; practice guideline; priority journal; randomized controlled trial (topic); Review; social support; treatment indication | - |
dc.title | Blood Glucose Management of Type 2 Diabetes in the Older People | en_US |
dc.type | Review | en |
dc.identifier.doi | 10.1016/j.ijge.2018.05.008 | - |
dc.identifier.scopus | 2-s2.0-85048874210 | - |
dc.relation.pages | 170-174 | - |
dc.relation.journalvolume | 12 | - |
dc.relation.journalissue | 3 | - |
item.openairetype | Review | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Clinical Medicine | - |
crisitem.author.orcid | 0000-0001-5087-373X | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。